Concert Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Concert Pharmaceuticals generated cash of -$55,154,000, which is more than the previous year. Cash used in financing activities reached the amount of $67,130,000 last year. Net change in cash is therefore $64,434,000.
Cash Flow
| 2012 | -26.42M | -1.2M | 12.16M |
|---|---|---|---|
| 2013 | 13.01M | -3.63M | -7.23M |
| 2014 | -29.76M | -44.45M | 77.97M |
| 2015 | 23.06M | 14.56M | 41.48M |
| 2016 | -45.34M | -7.21M | 601K |
| 2017 | 102.92M | -121.30M | 5.49M |
| 2018 | -48.02M | 37.90M | -169K |
| 2019 | -48.76M | 82.58M | 1.45M |
| 2020 | -69.03M | 344K | 92.85M |
| 2021 | -55.15M | 52.45M | 67.13M |
CNCE Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 78.35M | 54.2M | 18.92M | 29.22M | 40.55M | 92.51M | 13.39M | 9.63M | 7.49M | 22.94M |
Operating activities | ||||||||||
Net income | -80.05M | -74.76M | -78.16M | -56.02M | 95.63M | -50.72M | 24.17M | -31.69M | -6.05M | -20.44M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.47M | 1.60M | 1.66M | 1.24M | 1.00M | 893K | 785K | 1.05M | 1.34M | 1.45M |
Stock-based compensation expense | 12.57M | 11.11M | 10.32M | 11.5M | 8.5M | 5.06M | 2.98M | 1.69M | 1.00M | 868K |
| Deferred income tax benefit | 12.57M | 11.11M | 10.32M | 11.5M | 8.5M | 5.06M | 2.98M | 1.69M | 1.00M | 868K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -65K | -81K | -57K | 119K | -107K | 43K | 951K | -851K | -157K | 487K |
Inventories | 0 | -2.21M | 16.41M | 686K | -2.62M | -690K | -535K | 2.63M | 96K | 0 |
Accounts payable | 2.26M | -651K | -217K | 435K | 113K | 44K | -90K | -32K | 158K | -764K |
Cash generated by operating activities | -55.15M | -69.03M | -48.76M | -48.02M | 102.92M | -45.34M | 23.06M | -29.76M | 13.01M | -26.42M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -156.67M | -97.83M | -99.43M | -206.20M | -132.34M | -163.02M | -89.18M | -29.92M | -38.39M |
Investments In Property Plant And Equipment | -255K | -210K | -685K | -2.86M | -947K | -770K | -868K | -804K | -363K | -468K |
Acquisitions Net | 0 | 0 | -82.58M | 0 | 0 | 0 | 0 | 117K | 4K | 0 |
Cash generated by investing activities | 52.45M | 344K | 82.58M | 37.90M | -121.30M | -7.21M | 14.56M | -44.45M | -3.63M | -1.2M |
Financing activities | ||||||||||
Common Stock Issued | 66.99M | 92.01M | 115K | 0 | 512K | 0 | 46.99M | 87.58M | 32K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -740K | -1.20M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.18M | -5.24M | -332K |
Cash used in financing activities | 67.13M | 92.85M | 1.45M | -169K | 5.49M | 601K | 41.48M | 77.97M | -7.23M | 12.16M |
Net Change In Cash | 64.43M | 24.15M | 35.27M | -10.29M | -12.89M | -51.95M | 79.11M | 3.75M | 2.14M | -15.45M |
Cash at end of period | 142.79M | 78.35M | 54.2M | 18.92M | 27.66M | 40.55M | 92.51M | 13.39M | 9.63M | 7.49M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |